• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 SAFESTEP HUBER NEEDLE SET 20G X 1 IN; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 SAFESTEP HUBER NEEDLE SET 20G X 1 IN; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Model Number N/A
Medical Device Problem Code Contamination /Decontamination Problem (2895)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 08/18/2023
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The device has not been returned to the manufacturer for evaluation.
 
Event or Problem Description
It was reported that when saline solution was infused, a foreign material was found and the device could not be primed.There was no reported patient involvement.No other information was provided.
 
Additional Manufacturer Narrative
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.Based on a review of this information, the following was concluded: the complaint of a foreign material found in an infusion set is confirmed but the exact cause could not be determined.One 22 ga x 1.0 in.Safestep infusion set was returned for evaluation.A microscopic observation of the returned safestep infusion set revealed a grayish/brown fibrous material inside the luer of the device.The infusion set was returned opened with its original packaging and some use residues throughout the returned infusion set.Because the safestep infusion set was returned opened, the complaint is confirmed but the root cause could not be identified.This complaint will be recorded for future trending and monitoring purposes.H3 other text: evaluation findings are in section h11.
 
Event or Problem Description
It was reported that when saline solution was infused, a foreign material was found and the device could not be primed.There was no reported patient involvement.No other information was provided.
 
Event or Problem Description
It was reported that when saline solution was infused, a foreign material was found and the device could not be primed.There was no reported patient involvement.No other information was provided.
 
Additional Manufacturer Narrative
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SAFESTEP HUBER NEEDLE SET 20G X 1 IN
Common Device Name
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer Contact
kayla bevins
605 north 5600 west
salt lake city 84116
8015950700
MDR Report Key17708926
Report Number3006260740-2023-03990
Device Sequence Number17821779
Product Code FPA
UDI-Device Identifier00801741066221
UDI-Public(01)00801741066221
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K153440
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 01/23/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date05/20/2024
Device Model NumberN/A
Device Catalogue NumberLH-0032
Device Lot NumberASFSF119
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/21/2023
Supplement Date Received by Manufacturer01/03/2024
01/10/2024
Initial Report FDA Received Date09/08/2023
Supplement Report FDA Received Date01/05/2024
01/24/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured05/01/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-